Estee Lauder Companies Inc
XMUN:ELAA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Estee Lauder Companies Inc
XMUN:ELAA
|
US |
|
B
|
Bristol-Myers Squibb Co
XHAM:BRM
|
US |
|
N
|
Novartis AG
XMUN:NOT
|
CH |
|
A
|
AstraZeneca PLC
XMUN:ZEGA
|
UK |
|
B
|
BNP Paribas SA
DUS:BNP
|
FR |
|
S
|
Southwest Airlines Co
F:SWN
|
US |
|
G
|
Goodfellow Inc
OTC:GFELF
|
CA |
|
Carriage Services Inc
NYSE:CSV
|
US |
|
Ezenia! Inc
OTC:EZEN
|
US |
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
SBC Exports Ltd
NSE:SBC
|
IN |
Wall St Price Targets
ELAA Price Targets Summary
Estee Lauder Companies Inc
According to Wall Street analysts, the average 1-year price target for ELAA is 80.5 EUR with a low forecast of 58.58 EUR and a high forecast of 108.75 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ELAA's stock price target?
Price Target
80.5
EUR
According to Wall Street analysts, the average 1-year price target for ELAA is 80.5 EUR with a low forecast of 58.58 EUR and a high forecast of 108.75 EUR.
What is the Revenue forecast for Estee Lauder Companies Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Estee Lauder Companies Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 8 years is 13%.
